Propeller Health announced today that it raised $14.5 million in its Series B financing round, which was led by Safeguard Scientifics.

According to a release, Propeller Health will use the money to accelerate product development, strategic alliances, client services, sales and marketing.

“We’re fortunate to have the backing of partners with expertise in scaling enterprise and consumer digital health solutions,” CEO David Van Sickle said in a statement. “Together we aim to change the day-to-day life of people with chronic respiratory disease and the physicians who care for them.”

The Social+Capital Partnership also participated in the financing round.